Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Guideline concordant osimertinib and durvalumab in two US non-small cell lung cancer cohorts.”.
Christopher D’Avella, Igor Makhlin, Mengru Wang, Maneet Kaur, Yunzhi Qian +4 more